A placebo-adjusted effect of the initial eGFR decline following SGLT-2 inhibitor initia-tion: a systematic review and meta-analysis
{{output}}
Introduction: Sodium-glucose cotransporter-2 inhibitors (SGLT-2i) are pivotal in managing heart failure (HF), chronic kidney disease (CKD), and type 2 diabetes mellitus. While their beneficial impact is well-established, the init... ...
